Cargando…
Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic malignancy often associated with poor outcomes. To identify high-risk factors and potential actionable targets for T-ALL, we perform integrated genomic and transcriptomic analyses on samples from 165 Chinese pediatric and adult...
Autores principales: | Zhu, Haichuan, Dong, Bingjie, Zhang, Yingchi, Wang, Mei, Rao, Jianan, Cui, Bowen, Liu, Yu, Jiang, Qian, Wang, Weitao, Yang, Lu, Yu, Anqi, Li, Zongru, Liu, Chao, Zhang, Leping, Huang, Xiaojun, Zhu, Xiaofan, Wu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974951/ https://www.ncbi.nlm.nih.gov/pubmed/35399540 http://dx.doi.org/10.1097/BS9.0000000000000102 |
Ejemplares similares
-
3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia
por: Yang, Lu, et al.
Publicado: (2021) -
Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia
por: Liu, Xiaoming, et al.
Publicado: (2021) -
Pediatric Acute Lymphoblastic Leukemia Patients Exhibit Distinctive Alterations in the Gut Microbiota
por: Liu, Xiaoming, et al.
Publicado: (2020) -
Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Wang, Han, et al.
Publicado: (2022) -
LncRNA PPM1A-AS Regulate Tumor Development Through Multiple Signal Pathways in T-Cell Acute Lymphoblastic Leukemia
por: Li, Guoli, et al.
Publicado: (2021)